Women in Cancer Immunotherapy Network (WIN)

The Women in Cancer Immunotherapy Network (WIN) is a Society for Immunotherapy of Cancer (SITC) initiative seeking to promote and elevate women in the cancer immunotherapy field. Championed by SITC Past President Lisa H. Butterfield, PhD, the society's first female president, WIN provides a forum for women to discuss important topics relevant to their advancement in the field.

SITC is excited to announce the 2022 WIN Leadership Institute to be held in-person on Aug. 1-2, 2022 in Seattle, WA. The program, free of charge to accepted applicants, is professional development and a networking event that seek to empower emerging female leaders in the cancer immunotherapy field.

PROGRAM ORGANIZERS

• Lisa H. Butterfield, PhD – University of California San Francisco
• Olivera J. Finn, PhD - University of Pittsburgh
• Kristen Hege, MD - Bristol Myers Squibb
• Padmanee Sharma, MD, PhD - The University of Texas MD Anderson Cancer Center
• Cornelia Trimble, MD -  Johns Hopkins University 

2022 WIN Leadership Institute

This program features presentations from experienced female leaders, panel discussions allowing participants to ask questions and interact with these leaders and our distinguished program organizers, and virtual networking opportunities.

Applications were due March 2, 2022 at 5 p.m. PST.
  

SITC Professional Interest Communities are an original series of online communities created exclusively for SITC members. Within these communities, researchers and clinicians in the cancer immunotherapy field expand their network and receive career development support from colleagues.

The Women in SITC Community is open to women who share a common interest in immunology and cancer. Open to professional women, the goal of the community is to increase females in leadership roles within the society, foster connections and working opportunities among members, discuss immunotherapy toxicities (open to other specialties that deal with toxicity of immunotherapy), create mentorship opportunities, discuss gender bias and professional opportunities and contributions to the field of oncology/immunotherapy.

Not a member? Join SITC today and gain immediate access to the Women in SITC Community!